» Articles » PMID: 14749325

The Surface Coat of the Mammal-dwelling Infective Trypomastigote Stage of Trypanosoma Cruzi is Formed by Highly Diverse Immunogenic Mucins

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2004 Jan 30
PMID 14749325
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

A thick coat of mucin-like glycoproteins covers the surface of Trypanosoma cruzi and plays a crucial role in parasite protection and infectivity and host immunomodulation. The appealing candidate genes coding for the mucins of the mammal-dwelling stages define a heterogeneous family termed TcMUC, which comprises up to 700 members, thus precluding a genetic approach to address the protein core identity. Here, we demonstrate by multiple approaches that the TcMUC II genes code for the majority of trypomastigote mucins. These molecules display a variable, non-repetitive, highly O-glycosylated central domain, followed by a short conserved C terminus and a glycosylphosphatidylinositol anchor. A simultaneous expression of multiple TcMUC II gene products was observed. Moreover, the C terminus of TcMUC II mucins, but not their central domain, elicited strong antibody responses in patients with Chagas' disease and T. crusi infected animals. This highly diverse coat of mucins may represent a refined parasite strategy to elude the mammalian host immune system.

Citing Articles

Potential of extracellular vesicles in the pathogenesis, diagnosis and therapy for parasitic diseases.

Pinheiro A, Torrecilhas A, Souza B, Cruz F, de Matos Guedes H, Ramos T J Extracell Vesicles. 2024; 13(8):e12496.

PMID: 39113589 PMC: 11306921. DOI: 10.1002/jev2.12496.


Guidelines for the purification and characterization of extracellular vesicles of parasites.

Fernandez-Becerra C, Xander P, Alfandari D, Dong G, Aparici-Herraiz I, Rosenhek-Goldian I J Extracell Biol. 2024; 2(10):e117.

PMID: 38939734 PMC: 11080789. DOI: 10.1002/jex2.117.


Protective Efficacy of the Epitope-Conjugated Antigen N-Tc52/TSkb20 in Mitigating Infection through CD8+ T-Cells and IFNγ Responses.

Vazquez M, Zabala B, Mesias A, Biscari L, Kaufman C, Alloatti A Vaccines (Basel). 2024; 12(6).

PMID: 38932350 PMC: 11209121. DOI: 10.3390/vaccines12060621.


An α-Gal antigenic surrogate as a biomarker of treatment evaluation in Trypanosoma cruzi-infected children. A retrospective cohort study.

Abal M, Balouz V, Lopez R, Giorgi M, Marino C, Cruz C PLoS Negl Trop Dis. 2024; 18(1):e0011910.

PMID: 38236916 PMC: 10826959. DOI: 10.1371/journal.pntd.0011910.


Genome-wide chromatin interaction map for Trypanosoma cruzi.

Diaz-Viraque F, Chiribao M, Libisch M, Robello C Nat Microbiol. 2023; 8(11):2103-2114.

PMID: 37828247 PMC: 10627812. DOI: 10.1038/s41564-023-01483-y.